PROFUND ADVISORS LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$3,251,000
+99.2%
38,237
-17.0%
0.17%
+83.5%
Q2 2020$1,632,000
+223.2%
46,055
+23.1%
0.09%
+139.5%
Q1 2020$505,000
-54.9%
37,427
-29.3%
0.04%
-22.4%
Q4 2019$1,119,000
+94.3%
52,904
+21.8%
0.05%
+69.0%
Q3 2019$576,000
-9.7%
43,424
-5.6%
0.03%
-3.3%
Q2 2019$638,000
-33.5%
46,005
-8.0%
0.03%
-34.8%
Q1 2019$960,000
+35.6%
49,988
+0.7%
0.05%
+4.5%
Q4 2018$708,000
-42.6%
49,647
-16.2%
0.04%
-6.4%
Q3 2018$1,234,00059,2220.05%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders